bpc 157 for disc bulge Peptides & Decompression Therapy at Flex Spine and Sport BPC 157 (Body Protection Compound-157)
Description
So what is the current status of BPC 157
(1998) Effects of low-dose recombinant human insulin-like growth factor-I on insulin sensitivity, growth hormone and glucagon levels in young adults with insulin-dependent diabetes mellitus
Chemical Makeup Molecular Formula: C 78 H 123 N 23 O 23 S 2 Molecular Weight: 1815.12 g/mol Other Known Titles: Tyr-hGH Fragment 177-191 Research and Clinical Studies AOD 9604 Peptide and Lipolytic Activity Early studies were carried out on obese mice where the AOD 9604 peptide was periodically introduced for 14 days
Because AOD-9604 does not suppress appetite, patients describe it as a gentle metabolic upgrade rather than a forced calorie cut, sustainable and easy to live with
No, it is not FDA-approved, and much of the evidence is preclinical
Research is ongoing and the peptide doesnt have FDA approval
